C-P Assay kit CLIA

Primary DI

06974521001409

Basic UDI-DI Code

B-06974521001409

Reference

SUPM082072

Device Types

Single use

Regulation

Eu Ivdd

Classification

Eu Ivd General

Status

On The Market

Manufacturer

Shenzhen Superbio Technology Co.,Ltd.

This kit is used for in vitro quantitative detection of C-peptide (C-P) in human serum, plasma and (or) urine. C-peptide (C-P), also known as connecting peptide, is secreted by pancreatic beta cells, and it shares a common precursor with insulin, proinsulin. Proinsulin is split into 1 molecule of insulin and 1 molecule of C-P, so the molar amount of C-P and self-insulin is the same. Because C-P is not easily degraded by the liver, the measurement of C-P is the measurement of insulin content, which can accurately reflect the function of islet cells. During the oral glucose tolerance test, blood can be drawn to measure the serum C-P level 1 hour, 2 hours, and 3 hours after fasting blood glucose load. The C-P level of normal people increased to more than 3 times the basal level after 60 minutes of glucose intake. The level of C-P in type 1 diabetes is extremely low, and the postprandial increase in C-P in patients with islet dysfunction is often less than 3-fold. For patients receiving insulin therapy, auto-islet function cannot be evaluated by measuring insulin levels in blood, but auto-islet β-cell function can be evaluated by measuring C-P levels.

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).